User profiles for "author:Angela Lam"
Angela LamArbutus Biopharma Verified email at arbutusbio.com Cited by 3928 |
[HTML][HTML] Systematic benchmarking of omics computational tools
Computational omics methods packaged as software have become essential to modern
biological research. The increasing dependence of scientists on these powerful software …
biological research. The increasing dependence of scientists on these powerful software …
Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective
treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable …
treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable …
[HTML][HTML] Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977
E Murakami, T Tolstykh, H Bao, C Niu… - Journal of biological …, 2010 - ASBMB
A phosphoramidate prodrug of 2′-deoxy-2′-α-fluoro-β-C-methyluridine-5′-
monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in …
monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in …
Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus
AM Lam, C Espiritu, S Bansal… - Antimicrobial agents …, 2012 - Am Soc Microbiol
ABSTRACT PSI-7977, a prodrug of 2′-F-2′-C-methyluridine monophosphate, is the
purified diastereoisomer of PSI-7851 and is currently being investigated in phase 3 clinical …
purified diastereoisomer of PSI-7851 and is currently being investigated in phase 3 clinical …
PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus …
AM Lam, E Murakami, C Espiritu… - Antimicrobial agents …, 2010 - Am Soc Microbiol
The hepatitis C virus (HCV) NS5B RNA polymerase facilitates the RNA synthesis step during
the HCV replication cycle. Nucleoside analogs targeting the NS5B provide an attractive …
the HCV replication cycle. Nucleoside analogs targeting the NS5B provide an attractive …
[HTML][HTML] Eosinophilic esophagitis: New molecules, better life?
AY Lam, C Ma, JK Lee, AJ Bredenoord - Current opinion in pharmacology, 2022 - Elsevier
Eosinophilic esophagitis (EoE) is an antigen-mediated chronic T helper type 2 (Th2)-
associated inflammatory disorder that has emerged in the last three decades as an …
associated inflammatory disorder that has emerged in the last three decades as an …
High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein
K Klumpp, AM Lam, C Lukacs… - Proceedings of the …, 2015 - National Acad Sciences
The hepatitis B virus (HBV) core protein is essential for HBV replication and an important
target for antiviral drug discovery. We report the first, to our knowledge, high-resolution …
target for antiviral drug discovery. We report the first, to our knowledge, high-resolution …
Structure of hepatitis C virus polymerase in complex with primer-template RNA
The replication of the hepatitis C viral (HCV) genome is accomplished by the NS5B RNA-
dependent RNA polymerase (RdRp), for which mechanistic understanding and structure …
dependent RNA polymerase (RdRp), for which mechanistic understanding and structure …
Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase
Mutations were introduced into the NS3 helicase region of a hepatitis C virus (HCV) Con1
subgenomic replicon to ascertain the role of the helicase in viral replication. One new …
subgenomic replicon to ascertain the role of the helicase in viral replication. One new …
Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants
AM Lam, S Ren, C Espiritu, M Kelly, V Lau… - Antimicrobial agents …, 2017 - Am Soc Microbiol
The hepatitis B virus (HBV) core protein serves multiple essential functions in the viral life
cycle, and antiviral agents that target the core protein are being developed. Capsid …
cycle, and antiviral agents that target the core protein are being developed. Capsid …